$66.07
-0.89-1.33%
가까이에: Sep 24, 5:00 PM EST
$66.07
N/A
시간외: 4:00 PM EST
Benzinga
Benzinga
Benzinga
금요일, 9월 25
Arrowhead Pharmaceuticals Inc
ARWRNASDAQ
Arrowhead Pharma Earnings & Forecasts
Arrowhead Pharma (ARWR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Arrowhead Pharma Guidance
Recent Earnings Results
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.19 | $-1.14 | $0.02 | $-0.05 |
| Actual | $-1.36 | $-0.93 | $0.22 | $-0.18 |
| Surprise | -14.3% | +18.4% | +1000.0% | -260.0% |
| Revenue | ||||
| Estimate | $51.2M | $69.3M | $256.6M | $175.5M |
| Actual | $75.3M | $73.7M | $264.0M | $256.5M |
| Surprise | +47.1% | +6.45% | +2.89% | +46.1% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.55 | $-1.32 | $-1.27 | $-1.24 |
| Revenue | ||||
| Consensus | $60.2M | $46.8M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved